Hydralazine Hydrochloride Tablet
FDA Label NDC 51079-075

23 label sections · Submitted to the FDA by Mylan Institutional Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Mylan Institutional Inc. for the product Hydralazine Hydrochloride (NDC 51079-075). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, clinical pharmacology, indications and usage, contraindications, warnings, general, information for patients, laboratory tests, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.